Last Updated: August 9, 2026

Details for New Drug Application (NDA): 018689

✉ Email this page to a colleague

NDA 018689 describes RIDAURA, which is a drug marketed by Legacy and is included in one NDA. It is available from two suppliers. Additional details are available on the RIDAURA profile page.

The generic ingredient in RIDAURA is auranofin. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the auranofin profile page.

Summary for 018689

Tradename:	RIDAURA
Applicant:	Legacy
Ingredient:	auranofin
Patents:	0

Medical Subject Heading (MeSH) Categories for 018689

Antirheumatic Agents

Suppliers and Packaging for NDA: 018689

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
RIDAURA	auranofin	CAPSULE;ORAL	018689	NDA	Sebela Pharmaceuticals Inc.	54766-093	54766-093-06	60 CAPSULE in 1 BOTTLE (54766-093-06)
RIDAURA	auranofin	CAPSULE;ORAL	018689	NDA AUTHORIZED GENERIC	Coral Way Pharma, LLC	85437-093	85437-093-06	60 CAPSULE in 1 BOTTLE (85437-093-06)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	3MG
Approval Date:	May 24, 1985	TE:		RLD:	Yes

Expired US Patents for NDA 018689

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Legacy	RIDAURA	auranofin	CAPSULE;ORAL	018689-001	May 24, 1985	3,635,945	⤷ Start Trial
Legacy	RIDAURA	auranofin	CAPSULE;ORAL	018689-001	May 24, 1985	4,225,597	⤷ Start Trial
Legacy	RIDAURA	auranofin	CAPSULE;ORAL	018689-001	May 24, 1985	4,414,209	⤷ Start Trial
Legacy	RIDAURA	auranofin	CAPSULE;ORAL	018689-001	May 24, 1985	4,364,923	⤷ Start Trial
Legacy	RIDAURA	auranofin	CAPSULE;ORAL	018689-001	May 24, 1985	3,708,579	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.